NPI: 1295824498 · CANOGA PARK, CA 91303 · Community Health Clinic/Center · NPI assigned 10/12/2006
Authorized official PAHL, LINDA controls 20+ related entities in our dataset. Read more
| Authorized Official | PAHL, LINDA (CFO) |
| NPI Enumeration Date | 10/12/2006 |
Other providers sharing the same authorized official: PAHL, LINDA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 30,503 | $1.63M |
| 2019 | 17,795 | $932K |
| 2020 | 11,374 | $429K |
| 2021 | 17,535 | $863K |
| 2022 | 10,938 | $554K |
| 2023 | 15,014 | $909K |
| 2024 | 12,100 | $724K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 4,114 | 3,882 | $818K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 5,275 | 4,761 | $670K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 9,875 | 8,577 | $608K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 6,551 | 6,320 | $596K |
| S4993 | Contraceptive pills for birth control | 6,091 | 6,065 | $562K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1,742 | 1,664 | $544K |
| J3490 | Unclassified drugs | 14,936 | 12,618 | $524K |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 362 | 353 | $326K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 1,604 | 1,598 | $310K |
| 99201 | 2,084 | 1,836 | $253K | |
| 87806 | 6,305 | 4,856 | $156K | |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 400 | 387 | $153K |
| 11981 | 328 | 328 | $76K | |
| A4267 | Contraceptive supply, condom, male, each | 9,751 | 9,600 | $59K |
| 58300 | 587 | 293 | $52K | |
| 81025 | 14,443 | 13,892 | $45K | |
| J7303 | Contraceptive supply, hormone containing vaginal ring, each | 459 | 458 | $39K |
| J7304 | Contraceptive supply, hormone containing patch, each | 140 | 140 | $36K |
| S5000 | Prescription drug, generic | 5,413 | 4,921 | $35K |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | 2,425 | 2,425 | $31K |
| 99401 | 1,196 | 1,186 | $23K | |
| 11976 | 348 | 181 | $23K | |
| 83986 | 7,132 | 5,937 | $19K | |
| J7300 | Intrauterine copper contraceptive (paragard) | 28 | 28 | $19K |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | 4,474 | 4,358 | $16K |
| 99000 | 3,245 | 3,219 | $11K | |
| 86703 | 1,026 | 747 | $10K | |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | 1,412 | 1,373 | $5K |
| 81002 | 2,017 | 1,970 | $4K | |
| 90651 | 13 | 13 | $4K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 145 | 138 | $3K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 144 | 137 | $3K |
| 58301 | 82 | 41 | $2K | |
| 57454 | 30 | 15 | $2K | |
| 99402 | 45 | 45 | $1K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 203 | 178 | $1K |
| 82120 | 318 | 311 | $1K | |
| 87210 | 323 | 315 | $1K | |
| 86592 | 178 | 176 | $522.46 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 15 | 14 | $255.55 |